ATE415387T1 - Verfahren zur herstellung von benzonitrilen und benzimidosäure-derivaten - Google Patents

Verfahren zur herstellung von benzonitrilen und benzimidosäure-derivaten

Info

Publication number
ATE415387T1
ATE415387T1 AT03734040T AT03734040T ATE415387T1 AT E415387 T1 ATE415387 T1 AT E415387T1 AT 03734040 T AT03734040 T AT 03734040T AT 03734040 T AT03734040 T AT 03734040T AT E415387 T1 ATE415387 T1 AT E415387T1
Authority
AT
Austria
Prior art keywords
cysteine
benzimidoic
benzonitriles
producing
peptidal
Prior art date
Application number
AT03734040T
Other languages
English (en)
Inventor
Mukund S Chorghade
Mukund K Gurjar
Joseph Cherian
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of ATE415387T1 publication Critical patent/ATE415387T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/04—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
    • C07C257/08—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers having carbon atoms of imino-carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/06—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols from sulfides, hydropolysulfides or polysulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/12—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by reactions not involving the formation of mercapto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT03734040T 2002-05-15 2003-05-15 Verfahren zur herstellung von benzonitrilen und benzimidosäure-derivaten ATE415387T1 (de)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US38089502P 2002-05-15 2002-05-15
US38102102P 2002-05-15 2002-05-15
US38090302P 2002-05-15 2002-05-15
US38090902P 2002-05-15 2002-05-15
US38091002P 2002-05-15 2002-05-15
US38088002P 2002-05-15 2002-05-15
US38087802P 2002-05-15 2002-05-15
US38101302P 2002-05-15 2002-05-15
US38101202P 2002-05-15 2002-05-15
US38101702P 2002-05-15 2002-05-15
US38089402P 2002-05-15 2002-05-15
US39283302P 2002-06-27 2002-06-27

Publications (1)

Publication Number Publication Date
ATE415387T1 true ATE415387T1 (de) 2008-12-15

Family

ID=29554649

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03734040T ATE415387T1 (de) 2002-05-15 2003-05-15 Verfahren zur herstellung von benzonitrilen und benzimidosäure-derivaten

Country Status (6)

Country Link
US (17) US6903220B2 (de)
EP (2) EP1506162B1 (de)
JP (3) JP2005538950A (de)
AT (1) ATE415387T1 (de)
AU (2) AU2003239472A1 (de)
WO (2) WO2003097622A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT500490A1 (de) * 2001-10-16 2006-01-15 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von substituierten thiazolinen und deren zwischenprodukte
US20080086494A1 (en) * 2006-09-11 2008-04-10 Apple Computer, Inc. Transfer and synchronization of media data
US6903220B2 (en) * 2002-05-15 2005-06-07 Genzyme Corporation Synthesis of chiral 2-alkyl amino acids
US7394410B1 (en) * 2004-02-13 2008-07-01 Samplify Systems, Inc. Enhanced data converters using compression and decompression
DE602005023466D1 (de) * 2004-07-22 2010-10-21 Mitsubishi Gas Chemical Co Asymmetrische l-aminosäureamid-hydrolase und dafür codierende dna
DE102005054362A1 (de) 2004-12-01 2006-06-08 Degussa Ag Verfahren zur Herstellung von Amino- oder Hydroxybenzonitrilen
CA2602336A1 (en) * 2005-03-31 2006-10-05 Ucb Pharma S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
EP1879567A1 (de) 2005-04-28 2008-01-23 Pfizer Limited Aminosäurederivate
JP2006312614A (ja) * 2005-05-09 2006-11-16 Ajinomoto Co Inc チアゾリン化合物および光学活性α−アルキルシステインの製造方法
WO2008051552A2 (en) * 2006-10-25 2008-05-02 Northwestern University Organic semiconductor materials and methods of preparing and use thereof
US7799934B2 (en) * 2007-06-29 2010-09-21 University Of South Florida Enantioselective ring-opening of aziridines
EP2334620B1 (de) * 2008-09-05 2018-09-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur enantioselektiven trennung chiraler systeme mit verbindungsbildung unter anwendung von zwei aufeinanderfolgenden kristallisationsschritten
US8765817B1 (en) 2008-12-03 2014-07-01 Arrowhead Center, Inc. Selective inhibitors of EG5 motors and methods of use
US8349899B1 (en) 2008-12-03 2013-01-08 Arrowhead Center, Inc. Selective inhibitors of EG5 motors and methods of use
CN102549138B (zh) * 2009-06-29 2015-04-01 伊诺莱克斯投资公司 不含石化衍生中性氨基酸酯的阳离子型乳化剂及其组合物和方法
US9828324B2 (en) 2010-10-20 2017-11-28 Sirrus, Inc. Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
US10414839B2 (en) 2010-10-20 2019-09-17 Sirrus, Inc. Polymers including a methylene beta-ketoester and products formed therefrom
US9279022B1 (en) 2014-09-08 2016-03-08 Sirrus, Inc. Solution polymers including one or more 1,1-disubstituted alkene compounds, solution polymerization methods, and polymer compositions
EP2630191A4 (de) * 2010-10-20 2015-05-20 Sirrus Inc Synthese substantiell verunreinigungsfreier methylen-malonate
US9249265B1 (en) 2014-09-08 2016-02-02 Sirrus, Inc. Emulsion polymers including one or more 1,1-disubstituted alkene compounds, emulsion methods, and polymer compositions
CA2853073A1 (en) 2011-10-19 2013-04-25 Bioformix Inc. Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
CN102775399A (zh) * 2011-12-27 2012-11-14 盛世泰科生物医药技术(苏州)有限公司 arylhydrocarbon受体(AHR)的内源性配体,2-(1’H3’-吲哚羰基)噻唑-4-羧酸甲酯的合成新方法
US9181365B2 (en) 2012-03-30 2015-11-10 Sirrus, Inc. Methods for activating polymerizable compositions, polymerizable systems, and products formed thereby
US9234107B2 (en) 2012-03-30 2016-01-12 Sirrus, Inc. Ink coating formulations and polymerizable systems for producing the same
US10913875B2 (en) 2012-03-30 2021-02-09 Sirrus, Inc. Composite and laminate articles and polymerizable systems for producing the same
US10047192B2 (en) 2012-06-01 2018-08-14 Sirrus, Inc. Optical material and articles formed therefrom
EP2920231B1 (de) 2012-11-16 2020-05-06 Sirrus, Inc. Kunststoffverbindungssysteme und verfahren
CN105164797B (zh) 2012-11-30 2019-04-19 瑟拉斯公司 用于电子应用的复合组合物
WO2014110388A1 (en) 2013-01-11 2014-07-17 Bioformix Inc. Method to obtain methylene malonate via bis(hydroxymethyl) malonate pathway
US9315597B2 (en) 2014-09-08 2016-04-19 Sirrus, Inc. Compositions containing 1,1-disubstituted alkene compounds for preparing polymers having enhanced glass transition temperatures
US9416091B1 (en) 2015-02-04 2016-08-16 Sirrus, Inc. Catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US10501400B2 (en) 2015-02-04 2019-12-10 Sirrus, Inc. Heterogeneous catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US9334430B1 (en) 2015-05-29 2016-05-10 Sirrus, Inc. Encapsulated polymerization initiators, polymerization systems and methods using the same
US9217098B1 (en) 2015-06-01 2015-12-22 Sirrus, Inc. Electroinitiated polymerization of compositions having a 1,1-disubstituted alkene compound
US9518001B1 (en) 2016-05-13 2016-12-13 Sirrus, Inc. High purity 1,1-dicarbonyl substituted-1-alkenes and methods for their preparation
US9617377B1 (en) 2016-06-03 2017-04-11 Sirrus, Inc. Polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US9567475B1 (en) 2016-06-03 2017-02-14 Sirrus, Inc. Coatings containing polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US10428177B2 (en) 2016-06-03 2019-10-01 Sirrus, Inc. Water absorbing or water soluble polymers, intermediate compounds, and methods thereof
US10196481B2 (en) 2016-06-03 2019-02-05 Sirrus, Inc. Polymer and other compounds functionalized with terminal 1,1-disubstituted alkene monomer(s) and methods thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1050117B (it) 1969-09-17 1981-03-10 Godo Shusei Kk Metodo per la sintesi dell acido aeruginoico
DE2020866A1 (de) 1970-04-29 1971-11-18 Basf Ag Verfahren zur Herstellung von Hydroxy- und Aminobenzonitrilen
DE3002989A1 (de) 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
DE3170401D1 (en) 1980-07-28 1985-06-13 Ciba Geigy Ag Triazoline derivatives and processes for their preparation
GB9126832D0 (en) * 1991-12-18 1992-02-19 Sandoz Ltd Separation process
US5840739A (en) 1992-11-16 1998-11-24 University Of Florida Research Foundation, Inc. Thiazoline acid derivatives
WO1994011367A1 (en) 1992-11-16 1994-05-26 University Of Florida Research Foundation Inc. 2-(pyrid-2'-yl)-2-thiazoline-4(s)-carboxylic acid derivatives
CA2155130C (en) * 1993-02-26 1994-09-01 Janice M Hitchcock Xanthine derivatives as adenosine a1 receptor antagonists
US5554753A (en) 1993-08-25 1996-09-10 Indiana University Foundation Catalytic enantioselective synthesis of α-amino acid derivatives by phase-transfer catalysis
US5859001A (en) * 1996-01-11 1999-01-12 University Of Florida Research Foundation, Inc. Neuroprotective effects of polycyclic phenolic compounds
US6319914B1 (en) * 1993-11-05 2001-11-20 Apollo Biopharmaceuticals, Inc. Cytoprotective effect of polycyclic phenolic compounds
US5877169A (en) * 1993-11-05 1999-03-02 University Of Florida Research Foundation, Inc. Methods of treatment of ischemic damage
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US6197833B1 (en) * 1995-07-24 2001-03-06 Apollo Biopharmaceutics, Inc. Neuroprotective effects of polycyclic phenolic compounds
US6350739B1 (en) * 1999-08-11 2002-02-26 University Of Florida Resarch Foundation, Inc. Methods of prevention and treatment of ischemic damage
US5665890A (en) 1995-03-14 1997-09-09 President And Fellows Of Harvard College Stereoselective ring opening reactions
DE69714297T2 (de) 1996-03-10 2003-03-27 Reuter Chemische Apparatebau Kg Trennverfahren
JP2002501482A (ja) * 1997-01-16 2002-01-15 ユニバーシティ・オブ・フロリダ・リサーチ・ファンデーション・インコーポレーテッド 抗酸化剤との相乗的相互作用を通じて多環式フェノール化合物の細胞保護効果を強化するための組成物
EP1011838B1 (de) 1997-09-06 2006-05-24 Reuter Chemische Apparatebau KG Trennverfahren
WO1999026630A1 (en) * 1997-11-24 1999-06-03 University Of Florida Research Foundation, Incorporated Testosterone inhibitors and use for the protection of neurons
US6407281B1 (en) * 1998-01-13 2002-06-18 Kaneka Corporation Process for producing optically active cysteine derivatives
US5929252A (en) * 1998-06-15 1999-07-27 The Scripps Research Institute Aziridination of olefins
US6765109B1 (en) * 1998-06-29 2004-07-20 Roche Colorado Corporation Preparation of S-aryl-cysteine and its derivatives
EP1115702A4 (de) 1998-07-03 2002-04-17 Millennium Pharm Inc Durch stickstoff und schwefel substituierte alicyklische verbindungen und verfahren zu ihrer herstellung
US6083966A (en) 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
US6159983A (en) 1998-09-18 2000-12-12 University Of Florida Method and composition for treatment of inflammatory bowel disease
EP1143951A3 (de) 1998-09-21 2002-02-06 University Of Florida Research Foundation, Inc. Mittel gegen malaria
KR20010075000A (ko) * 1998-10-09 2001-08-09 에가시라 구니오 시스테인 유도체
US6326365B1 (en) * 1999-07-20 2001-12-04 Apollo Biopharmaceutics, Inc. Methods of prevention and treatment of ischemic damage
US6339078B1 (en) * 1999-07-20 2002-01-15 University Of Florida Research Foundation, Inc. Methods of prevention and treatment of ischemic damage
DE20000122U1 (de) * 2000-01-05 2000-04-20 ABT Advanced Bioanalytical Technology GmbH & Co KG, 01454 Radeberg Mobiles Handgerät mit wiederverwendbarem Biosensor
WO2001051477A1 (en) 2000-01-14 2001-07-19 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AT500490A1 (de) 2001-10-16 2006-01-15 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von substituierten thiazolinen und deren zwischenprodukte
US6903220B2 (en) 2002-05-15 2005-06-07 Genzyme Corporation Synthesis of chiral 2-alkyl amino acids
ITVR20020062A1 (it) * 2002-06-03 2003-12-03 Andrea Pretto Preparazione estemporanea di periossiacidi organici stabili nel tempo

Also Published As

Publication number Publication date
US20040002613A1 (en) 2004-01-01
US6794515B2 (en) 2004-09-21
US6875882B2 (en) 2005-04-05
US20030236435A1 (en) 2003-12-25
US6875883B2 (en) 2005-04-05
US7576234B2 (en) 2009-08-18
US7002036B2 (en) 2006-02-21
EP1506162B1 (de) 2008-11-26
AU2003239472A1 (en) 2003-12-02
US20060167267A1 (en) 2006-07-27
US20060281926A1 (en) 2006-12-14
WO2003097582A3 (en) 2004-02-12
US20030236426A1 (en) 2003-12-25
US6982335B2 (en) 2006-01-03
US20030236404A1 (en) 2003-12-25
EP1506162A2 (de) 2005-02-16
US6878828B2 (en) 2005-04-12
US20050209462A1 (en) 2005-09-22
US20030236434A1 (en) 2003-12-25
US20040024224A1 (en) 2004-02-05
JP4414331B2 (ja) 2010-02-10
US20060142586A1 (en) 2006-06-29
WO2003097582A2 (en) 2003-11-27
US7038073B2 (en) 2006-05-02
JP2005525427A (ja) 2005-08-25
WO2003097622A2 (en) 2003-11-27
US20060217561A1 (en) 2006-09-28
EP1529037B1 (de) 2009-07-15
US6903220B2 (en) 2005-06-07
US7285670B2 (en) 2007-10-23
US20030225287A1 (en) 2003-12-04
JP2007001986A (ja) 2007-01-11
US7285676B2 (en) 2007-10-23
AU2003247374A8 (en) 2003-12-02
EP1529037A2 (de) 2005-05-11
US20040006224A1 (en) 2004-01-08
US7115769B2 (en) 2006-10-03
US20040082796A1 (en) 2004-04-29
WO2003097622A3 (en) 2004-04-08
US20030220504A1 (en) 2003-11-27
AU2003247374A1 (en) 2003-12-02
US20030229231A1 (en) 2003-12-11
US20060069265A1 (en) 2006-03-30
JP2005538950A (ja) 2005-12-22
US7294718B2 (en) 2007-11-13
US6846958B2 (en) 2005-01-25
US6861532B2 (en) 2005-03-01

Similar Documents

Publication Publication Date Title
AU2003239472A1 (en) Synthesis of benzonitriles and benzimidates
DE60210772D1 (de) Verfahren zur herstellung von l-aminosäuren unter verwendung von stämmen der familie enterobacteriaceae
DE60138141D1 (de) Photosensibilisator und verfahren zu seiner herstellung
DE60229267D1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
ATE321024T1 (de) Verfahren zur herstellung von oxazolidinonverbindungen
PE20060692A1 (es) Inhibidores bace
DE69931753D1 (de) Azoverbindungen sowie verfahren zur herstellung derselben
NZ579296A (en) Spirocyclic compounds as inhibitors of serine proteases for the treatment of HCV infections
PE20020294A1 (es) Derivados de pirrolidina como inhibidores de la enzima conversor de endotelina
DE60131733D1 (de) Verfahren zur herstellung von (2s,3r,4s)-4-hydroxyisoleucin und analoga
DK1309535T3 (da) Fremgangsmåder til fremstilling af alfa'-chlorketoner
DE602004031129D1 (de) Verfahren zur herstellung von quetiapin
DE50309260D1 (de) Verfahren zur herstellung von bicalutamid
HUP9802146A2 (hu) Eljárás optikailag aktív 2-amino-omega-oxoalkánsav-származékok előállítására és a vegyületek
DE60040592D1 (de) Verfahren zur herstellung von alpha-aminoketonen
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE60039533D1 (de) Verbessertes verfahren zur herstellung von 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin
DE60007835D1 (de) Verfahren zur herstellung von chiralen aminosäuren
TR200000672T2 (tr) Epoksit aramaddeleri hazırlamak için bir işlem.
DE60015559D1 (de) Sentrin-spezifische menschliche protease senp1
ATE340569T1 (de) Verwendung eines neuen mittels zur verhütung von infektionen
NO20020328L (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
DE60336275D1 (de) Verfahren zur Herstellung von 3-(1,3-Dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als Dopamin-beta-hydroxylase Inhibitor
DE602004006896D1 (de) Bis-dicarbonsäuresalze von benazepril und herstellung von benazepril über diese salze
DE60218033D1 (de) Verfahren zur herstellung von l-aminosäuren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties